(E)-3α-hydroxy-6-ethylidene-7-keto-5β-cholan-24-oic acid NEW

$0.00 10kg

$0.00 5kg

$0.00 1kg

Min. Order1kg
Purity99%
Cas No1516887-33-4
Supply Ability500KG
Update time2025-07-08

Hangzhou ICH Biofarm Co., Ltd

VIP3Y

China

Since:2006-07-19

Address:Room 1305, Building A, No. 274 Tianmushan Road and No. 2-18 (Double) Wantang Road, Xihu District, Ha

show less show more

Chemical Properties

Product Name	(E)-3α-hydroxy-6-ethylidene-7-keto-5β-cholan-24-oic acid
CAS No	1516887-33-4
EC-No
Min. Order	1kg
Purity	99%
Supply Ability	500KG
Release date	2025/07/08

- (E)-3α-hydroxy-6-ethylidene-7-keto-5β-cholan-24-oic acid is a chemical compound with the formula C26H40O4, which is an intermediate for the synthesis of Obeticholic Acid.

- Its molecular weight is 416.59 g/mol and its melting point is 140-142 °C.

- Its structure contains a trans double bond between carbon atoms 6 and 7, which is similar to elaidic acid, a trans fatty acid found in hydrogenated vegetable oils.

- Obeticholic Acid is a synthetic bile acid analog that acts as a farnesoid X receptor agonist, and is used for the treatment of primary biliary cholangitis and nonalcoholic steatohepatitis.

Email: pharmchem1@ichemie.com

Tel&Whatsapp:+86-18771921569

show less show more

Company Profile Introduction

Our company specializes in the research, development and production of APIs and pharmaceutical intermediates. At the same time, our core R&D team has more than 20 years of drug R&D experience. Under the support of a good research and development environment and a professional technical team, our company has obtained rich experience and outstanding achievements of new drugs and generic drugs projects. On the one hand, we are focused on the research and development and the optimization of production processes of generic drugs such as anti-viral and anti-malaria. On the other hand, we are also committed to the cooperative development of innovative drugs in the fields of respiratory system and hypoglycemia. We can provide technical support in all key links of drug research and development for drug production and distribution companies.